In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Simple awareness campaign in general practice identifies new cases of AF

Atrial fibrillation and the risk of stroke

Atrial Fibrillation


Barcelona, Spain – Tuesday 2 September 2014: A simple awareness campaign in general practice identifies new cases of atrial fibrillation (AF), according to research presented at ESC Congress today by Professor Jean-Marc Davy from France.

Professor Davy said: “Atrial fibrillation (AF) is the most common cardiac arrhythmia. It multiplies the risk of heart failure risk by three-fold and the risk of stroke risk by five-fold. Similarly, AF is responsible for ischaemic stroke in 1 of 4 cases. However, AF is often overlooked and diagnosed too late. In 20% of cases, AF is diagnosed when a stroke occurs. We therefore designed a campaign to improve early diagnosis of AF.”

PROFIL FA is an AF awareness campaign in general practice. Participating general practitioners (GPs) were asked, on a given day, to look for several clinical items in all their consecutive patients over 65 years, according to a dedicated and very simple questionnaire (figure 1):

  • The 7 criteria of the thromboembolic risk score CHA2DS2-VASc
  • The existence of 4 symptoms, transient and suggestive of AF episodes: palpitations, chest pain, dyspnoea (shortness of breath) and asthenia (weakness)
  • Palpation of an irregular radial pulse.

When AF was suspected, GPs referred patients to a cardiologist for diagnostic confirmation.
The study included 603 physicians and 4 592 patients. AF had already been diagnosed in 840 patients (18% of cases) (figure 2). The remaining 3 752 patients were evaluated on a single day using the questionnaire. Of these, AF was clinically suspected in 585 patients (1 in 6) and they were referred to a cardiologist.
Out of the 585 patients in whom AF was suspected by the GP, 129 patients (nearly 1 in 4) had the existence of AF confirmed by the specialist who then prescribed appropriate treatment. Professor Davy said: “Our simple and easy campaign held on just one day led to the diagnosis of 129 patients with AF who then received treatment to reduce their risk of stroke.”

He added: “According to the ESC 2012 recommendations for AF,1 an irregular pulse should be systematically sought in all patients over 65 years to detect the presence of AF. But in PROFIL FA, an irregular pulse was linked to a diagnosis of AF in only 1 out of 2 cases. For patients without irregular heartbeat, the presence of two symptoms and/or a previous stroke history were also predictors of AF.”
Professor Davy concluded: “The detection of silent AF to prevent ischaemic stroke is by nature a technological challenge which requires the use of long term external or internal electrocardiogram (ECG) monitors. However, we have shown that unknown AF can be identified in the population over 65 years using a simple, precise pathway and a multidisciplinary approach.”


Figure 1: Dedicated questionnaire for the PROFIL FA campaign

Figure 2: Study flow and results of PROFIL FA

References

(1) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2012;33:2719–2747. doi:10.1093/eurheartj/ehs253

Notes to editor

About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
About ESC Congress 2014
The ESC Congress is currently the world's largest international congress in cardiovascular medicine.  The spotlight of this year's event is “innovation and the heart”.  ESC Congress 2014 takes place from 30 August to 3 September at the Fira Gran Via in Barcelona, Spain. For more information on ESC Congress 2014 contact the ESC Press Office.
To access all the scientific resources from the sessions during the congress, visit ESC Congress 365
This press release accompanies both a presentation and an ESC press conference at the ESC Congress 2014. Edited by the ESC from material supplied by the investigators themselves, this press release does not necessarily reflect the opinion of the European Society of Cardiology. The content of the press release has been approved by the presenter.